PortfoliosLab logoPortfoliosLab logo
GLMD vs. CPRT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GLMD vs. CPRT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Galmed Pharmaceuticals Ltd. (GLMD) and Copart, Inc. (CPRT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GLMD achieves a -9.39% return, which is significantly higher than CPRT's -22.48% return. Over the past 10 years, GLMD has underperformed CPRT with an annualized return of -50.29%, while CPRT has yielded a comparatively higher 17.40% annualized return.


GLMD

1D
-1.61%
1M
15.57%
YTD
-9.39%
6M
-36.45%
1Y
-54.05%
3Y*
-77.13%
5Y*
-74.35%
10Y*
-50.29%

CPRT

1D
-1.65%
1M
-8.83%
YTD
-22.48%
6M
-21.88%
1Y
-40.50%
3Y*
-11.65%
5Y*
-0.59%
10Y*
17.40%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GLMD vs. CPRT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GLMD
Galmed Pharmaceuticals Ltd.
-9.39%-76.47%-41.58%-93.93%-72.53%-41.48%-46.19%-15.37%-25.36%160.68%
CPRT
Copart, Inc.
-22.48%-31.78%17.12%60.95%-19.68%19.15%39.93%90.33%10.63%55.89%

Correlation

The correlation between GLMD and CPRT is 0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.00

Correlation (3Y)
Calculated over the trailing 3-year period

-0.02

Correlation (5Y)
Calculated over the trailing 5-year period

0.01

Correlation (10Y)
Calculated over the trailing 10-year period

0.08

Correlation (All Time)
Calculated using the full available price history since Mar 14, 2014

0.09

The correlation between GLMD and CPRT shifts across timeframes, from -0.02 (3 years) to 0.09 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

GLMD:

$4.48M

CPRT:

$29.29B

EPS

GLMD:

-$1.93

CPRT:

$1.59

PB Ratio

GLMD:

0.28

CPRT:

3.34

Total Revenue (TTM)

GLMD:

$0.00

CPRT:

$4.64B

Gross Profit (TTM)

GLMD:

$0.00

CPRT:

$2.11B

EBITDA (TTM)

GLMD:

-$8.49M

CPRT:

$2.00B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GLMD vs. CPRT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GLMD
GLMD Risk / Return Rank: 1717
Overall Rank
GLMD Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
GLMD Sortino Ratio Rank: 1616
Sortino Ratio Rank
GLMD Omega Ratio Rank: 1818
Omega Ratio Rank
GLMD Calmar Ratio Rank: 1616
Calmar Ratio Rank
GLMD Martin Ratio Rank: 2121
Martin Ratio Rank

CPRT
CPRT Risk / Return Rank: 11
Overall Rank
CPRT Sharpe Ratio Rank: 00
Sharpe Ratio Rank
CPRT Sortino Ratio Rank: 11
Sortino Ratio Rank
CPRT Omega Ratio Rank: 11
Omega Ratio Rank
CPRT Calmar Ratio Rank: 00
Calmar Ratio Rank
CPRT Martin Ratio Rank: 11
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GLMD vs. CPRT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Galmed Pharmaceuticals Ltd. (GLMD) and Copart, Inc. (CPRT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GLMDCPRTDifference
Sharpe ratioReturn per unit of total volatility

+1.09

Sortino ratioReturn per unit of downside risk

+1.87

Omega ratioGain probability vs. loss probability

0.92

0.69

+0.23

Calmar ratioReturn relative to maximum drawdown

-0.68

-1.02

+0.34

Martin ratioReturn relative to average drawdown

-0.97

-1.86

+0.89

GLMD vs. CPRT - Sharpe Ratio Comparison

The current GLMD Sharpe Ratio is -0.63, which is higher than the CPRT Sharpe Ratio of -1.72. The chart below compares the historical Sharpe Ratios of GLMD and CPRT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


GLMDCPRTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.63

-1.72

+1.09

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.45

-0.02

-0.43

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.37

0.64

-1.00

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.38

0.48

-0.85

Drawdowns

GLMD vs. CPRT - Drawdown Comparison

The maximum GLMD drawdown since its inception was -99.99%, which is greater than CPRT's maximum drawdown of -72.49%. Use the drawdown chart below to compare losses from any high point for GLMD and CPRT.


Loading charts...

Drawdown Indicators


GLMDCPRTDifference

Max Drawdown

Largest peak-to-trough decline

-99.99%

-72.49%

-27.50%

Max Drawdown (1Y)

Largest decline over 1 year

-79.62%

-39.90%

-39.72%

Max Drawdown (3Y)

Largest decline over 3 years

-99.11%

-52.46%

-46.65%

Max Drawdown (5Y)

Largest decline over 5 years

-99.93%

-52.46%

-47.47%

Max Drawdown (10Y)

Largest decline over 10 years

-99.99%

-52.46%

-47.53%

Current Drawdown

Current decline from peak

-99.98%

-52.46%

-47.52%

Average Drawdown

Average peak-to-trough decline

-74.35%

-16.54%

-57.81%

Ulcer Index

Depth and duration of drawdowns from previous peaks

55.49%

22.42%

+33.07%

Volatility

GLMD vs. CPRT - Volatility Comparison

Galmed Pharmaceuticals Ltd. (GLMD) has a higher volatility of 25.28% compared to Copart, Inc. (CPRT) at 8.81%. This indicates that GLMD's price experiences larger fluctuations and is considered to be riskier than CPRT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GLMDCPRTDifference

Volatility (1M)

Calculated over the trailing 1-month period

25.28%

8.81%

+16.47%

Volatility (6M)

Calculated over the trailing 6-month period

62.60%

18.64%

+43.96%

Volatility (1Y)

Calculated over the trailing 1-year period

86.30%

23.59%

+62.71%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

166.29%

25.94%

+140.35%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

137.58%

27.43%

+110.15%

Dividends

GLMD vs. CPRT - Dividend Comparison

Neither GLMD nor CPRT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

GLMD vs. CPRT - Financials Comparison

This section allows you to compare key financial metrics between Galmed Pharmaceuticals Ltd. and Copart, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B1.20B202220232024202520260
1.24B
(GLMD) Total Revenue
(CPRT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


GLMD and CPRT have a correlation of 0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GLMD has higher volatility (25.28%) compared to CPRT (8.81%). In terms of maximum drawdown, GLMD dropped -99.99% vs CPRT's -72.49%.

GLMD currently has the higher Sharpe Ratio (-0.63 vs -1.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GLMD and CPRT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer